GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Entheon Biomedical Corp (OTCPK:ENTBF) » Definitions » ROE % Adjusted to Book Value

Entheon Biomedical (Entheon Biomedical) ROE % Adjusted to Book Value : -38.07% (As of Feb. 2024)


View and export this data going back to 2020. Start your Free Trial

What is Entheon Biomedical ROE % Adjusted to Book Value?

Entheon Biomedical's ROE % for the quarter that ended in Feb. 2024 was -109.27%. Entheon Biomedical's PB Ratio for the quarter that ended in Feb. 2024 was 2.87. Entheon Biomedical's ROE % Adjusted to Book Value for the quarter that ended in Feb. 2024 was -38.07%.

Entheon Biomedical ROE % Adjusted to Book Value Historical Data

The historical data trend for Entheon Biomedical's ROE % Adjusted to Book Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Entheon Biomedical ROE % Adjusted to Book Value Chart

Entheon Biomedical Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Nov21 Nov22 Nov23
ROE % Adjusted to Book Value
Get a 7-Day Free Trial - - -51.09 -48.35 -31.99

Entheon Biomedical Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Feb21 May21 Aug21 Nov21 Feb22 May22 Aug22 Nov22 Feb23 May23 Aug23 Nov23 Feb24
ROE % Adjusted to Book Value Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -20.33 -7.74 -25.95 -41.75 -38.07

Competitive Comparison of Entheon Biomedical's ROE % Adjusted to Book Value

For the Biotechnology subindustry, Entheon Biomedical's ROE % Adjusted to Book Value, along with its competitors' market caps and ROE % Adjusted to Book Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Entheon Biomedical's ROE % Adjusted to Book Value Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Entheon Biomedical's ROE % Adjusted to Book Value distribution charts can be found below:

* The bar in red indicates where Entheon Biomedical's ROE % Adjusted to Book Value falls into.


Entheon Biomedical ROE % Adjusted to Book Value Calculation

Entheon Biomedical's ROE % Adjusted to Book Value for the fiscal year that ended in Nov. 2023 is calculated as

ROE % Adjusted to Book Value=ROE % / PB Ratio
=-63.66% / 1.99
=-31.99%

Entheon Biomedical's ROE % Adjusted to Book Value for the quarter that ended in Feb. 2024 is calculated as

ROE % Adjusted to Book Value=ROE % / PB Ratio
=-109.27% / 2.87
=-38.07%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Entheon Biomedical ROE % Adjusted to Book Value Related Terms

Thank you for viewing the detailed overview of Entheon Biomedical's ROE % Adjusted to Book Value provided by GuruFocus.com. Please click on the following links to see related term pages.

Entheon Biomedical (Entheon Biomedical) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Entheon Biomedical Corp (OTCPK:ENTBF) » Definitions » ROE % Adjusted to Book Value
Comparable Companies
XCNQ:MYND XCNQ:ABRT XCNQ:WESA.X TSXV:BTI XCNQ:HAVN TSXV:IBO XCNQ:GTTX TSXV:APC.H XCNQ:MOOD XCNQ:NSHS OCSE:NOVO B VRTX REGN ASX:CSL SGEN XKRX:207940 MRNA HKSE:02269 XBRU:ARGX BNTX
Traded in Other Exchanges
1XU1:Germany ENBI:Canada
Address
999 West Broadway Street, Suite 720, Vancouver, BC, CAN, V5Z 1K5
Website
https://www.entheonbiomedical.com
Entheon Biomedical Corp is a biotechnology research and development company committed to developing and commercializing a portfolio of safe and effective Dimethyltryptamine based psychedelic therapeutic products (DMT Products) for the purposes of treating addiction and substance use disorders. Entheon intends to generate revenue through the sale of its DMT Products to physicians, clinics, and licensed psychiatrists in the United States, certain countries in the European Union, and throughout Canada.